プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Anujan R.に依頼

United States

Assistant Professor Pharmaceutical Sciences | Expert in Drug Delivery and Immunotherapy | 8+ years of experience

プロフィール概要

Assistant Professor of Pharmaceutical Sciences at the University of the Pacific, specializing in drug delivery of biologics, biomaterials, and immune-cell engineering. I help research teams design, optimize, and troubleshoot protein formulations, delivery systems, and mechanistic studies. Expertise includes high-concentration antibody formulations, IL-based excipients, long-acting depots, electroporation strategies, and in vitro/in vivo pharmacology. Available for consulting, data interpretation, technical writing, and project development.

専門分野

• ★ Nanotechnology & Nanomaterials
• ★ Drug Formulation
• ★ Immunotherapy
• ☆ Biotechnology & Bioengineering
• ☆ Biomedical Engineering
• ☆ Drug Discovery
• ☆ Allergy & Clinical Immunology
• ☆ Clinical Immunology
• ☆ Women's Health
• ☆ Breast Cancer

サービス

• Writing
• Research
• Consulting
• Product Development

Writing Clinical Trial Documentation, Medical Writing

Research Market Research, Feasibility Study, Gap Analysis

Consulting Business Strategy Consulting, Go-to-Market Strategy Consulting, Healthcare Consulting, Legal Consulting, Scientific and Technical Consulting

Product Development Formulation, Stability/Shelf Life Testing, Concept Development, Reverse Engineering

職務経験

Assistant Professor -Pharmaceutical Sciences

University of the Pacific

11月 2025 - 現在

Postdoctoral Fellow

Harvard University- Wyss Institute

4月 2023 - 現在

PhD Candidate

University of Massachusetts Amherst

8月 2019 - 現在

Research Assistant

University of Massachusetts Amherst

5月 2017 - 8月 2019

Research Assistant

Brigham and Women's Hospital

1月 2017 - 5月 2017

学歴

Biomedical Engineering

University of Massachusetts Amherst

9月 2019 - 5月 2023

Master of Business Administration

University of Massachusetts Amherst

9月 2019 - 5月 2023

B.Tech (Bioengineering )

SASTRA University

7月 2013 - 7月 2017

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Anujan Ramesh, Vaishali Malik, Anthony Brouillard, Ashish Kulkarni (2022). Supramolecular nanotherapeutics enable metabolic reprogramming of tumor‐associated macrophages to inhibit tumor growth . Journal of Biomedical Materials Research Part A.

Anujan Ramesh and Vaishali Malik and Hayat Anu Ranjani and Harriet Smith and Ashish A. Kulkarni(2021). Rational combination of an immune checkpoint inhibitor with CSF1R inhibitor–loaded nanoparticle enhances anticancer efficacy . Drug Delivery and Translational Research. Springer Science and Business Media {LLC}

Vaishali Malik and Anujan Ramesh and Ashish A. Kulkarni(2021). TLR7/8 Agonist and SHP2 Inhibitor Loaded Nanoparticle Enhances Macrophage Immunotherapy Efficacy . Advanced Therapeutics. 4. (8). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2100086. Wiley

Anujan Ramesh, Anthony Brouillard, Ashish Kulkarni(2021). Supramolecular Nanotherapeutics for Macrophage Immunotherapy . ACS Applied Bio Materials. 4. (6). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 4653--4666. American Chemical Society ({ACS})

Anh Nguyen and Anujan Ramesh and Sahana Kumar and Dipika Nandi and Anthony Brouillard and Alexandria Wells and Leonid Pobezinsky and Barbara Osborne and Ashish A. Kulkarni(2020). Granzyme B nanoreporter for early monitoring of tumor response to immunotherapy . Science Advances. 6. (40). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString eabc2777. American Association for the Advancement of Science ({AAAS})

Anujan Ramesh and Sahana Kumar and Anthony Brouillard and Dipika Nandi and Ashish Kulkarni(2020). A Nitric Oxide (NO) Nanoreporter for Noninvasive Real‐Time Imaging of Macrophage Immunotherapy . Advanced Materials. 32. (24). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 2000648. Wiley

Sahana Kumar, Anujan Ramesh, Ashish Kulkarni(2020). Targeting macrophages: a novel avenue for cancer drug discovery . Expert Opinion on Drug Discovery. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 1--14. Informa {UK} Limited

(2020). Dual inhibition of CSF1R and MAPK pathways using supramolecular nanoparticles enhances macrophage immunotherapy . Biomaterials.

Anujan Ramesh, Sahana Kumar, Anh Nguyen, Anthony Brouillard, Ashish Kulkarni(2020). Lipid-based phagocytosis nanoenhancer for macrophage immunotherapy . Nanoscale. Royal Society of Chemistry ({RSC})

Nilesh Deshpande and Anujan Ramesh and Dipika Nandi and Anh Nguyen and Anthony Brouillard and Ashish Kulkarni(2020). Supramolecular Polysaccharide Nanotheranostics that Inhibit Cancer Cells Growth and Monitor Targeted Therapy Response . Nanotheranostics. 4. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 156--172. Ivyspring International Publisher

(2019). CSF1R‐ and SHP2‐Inhibitor‐Loaded Nanoparticles Enhance Cytotoxic Activity and Phagocytosis in Tumor‐Associated Macrophages . Advanced Materials.

(2019). Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor . Cellular and Molecular Bioengineering.

(2018). A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer . Nature biomedical engineering.

BOOK CHAPTER

Anujan Ramesh and Ashish A. Kulkarni(2022). Delivery strategies for reprogramming tumor-associated macrophages . Systemic Drug Delivery Strategies. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 83--115. Elsevier